Stock Price Quote

LYKA LABS LTD.

NSE : LYKALABSBSE : 500259ISIN CODE : INE933A01014Industry : Pharmaceuticals & DrugsHouse : Private
BSE105.461.63 (+1.57 %)
PREV CLOSE ( ) 103.83
OPEN PRICE ( ) 106.07
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 10611
TODAY'S LOW / HIGH ( )103.30 106.68
52 WK LOW / HIGH ( )89 165
NSE105.751.25 (+1.2 %)
PREV CLOSE( ) 104.50
OPEN PRICE ( ) 105.05
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 105.75 (88)
VOLUME 166343
TODAY'S LOW / HIGH( ) 103.80 107.60
52 WK LOW / HIGH ( )88.5 164.4
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 29-12 1976
Management Info
Kunal N Gandhi - Chairman Kunal N Gandhi - Managing Director
Registered Office

Address 4801/B & 4802/A,G I D C Industrial Estate, ,
Ankleshwar,
Gujarat-393002

Phone 02646221422 /220549

Email companysecretary@lykalabs.com

Website www.lykalabs.com

Registrars Details
Link Intime India Pvt Ltd.
C 101, 247 Park,L B S Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE

NEWS

24May Lyka Labs informs about newspaper publ
Pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosur..
18Apr Allotment of Convertible warrants
Inter alia considered the allotment and issue of 24,00,000 Equity Shares..
18Apr Allotment of Equity Shares
Inter alia considered the allotment and issue of 24,00,000 Equity Shares..
11Apr Allotment of Convertible warrants
Inter alia: to allot and issue 24,00,000 Equity Shares upon conversion o..
03Apr Lyka Labs informs about loss of share
Lyka Labs has informed that the Company has issued Duplicate Share Certi..

Financials

in Millions
QTR Mar 23 ANNUAL 23
Net Profit-30.03-132.86
Gross Profit -29.28 -132.08
Operating Profit 33.46190.52
Net Sales 194.55805.93

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

NGL Fine-Chem (BSE)
peergroup  1778.35 (16.32%)
M.Cap ( in Cr)1098.67
Abbott India (BSE)
peergroup  21808.15 (0.77%)
M.Cap ( in Cr)46340.80
RPG Life Sciences (BSE)
peergroup  922.05 (11.90%)
M.Cap ( in Cr)1524.98
AMI Organics (BSE)
peergroup  1277.75 (3.02%)
M.Cap ( in Cr)4655.75
Mankind Pharma (BSE)
peergroup  1482.55 (1.79%)
M.Cap ( in Cr)59389.24

Shareholding Pattern

PROMOTERS 51%
NON-INSTITUTION 45.08%
MUTUAL FUNDS/UTI 3.31%
FI/BANKS/INSURANCE 0.43%
GOVERNMENT 0%
FII 0%

Mf Holdings

Scheme NameHold(%)
Quant Active Fund(G)0.29

About Lyka Labs Ltd.

Lyka Labs Ltd. was incorporated in the year 1976. Its today's share price is 105.46. Its current market capitalisation stands at Rs 348.97 Cr. In the latest quarter, company has reported Gross Sales of Rs. 1643.49 Cr and Total Income of Rs.1670.69 Cr. The company's management includes Babulal Jain, Shashil P Mendonsa, Kishore P Shah, Dhara P Shah, Sandeep P Parikh, Prashant P Godha, Yogesh Shah, Kunal N Gandhi, Kunal N Gandhi.

It is listed on the BSE with a BSE Code of 500259 , NSE with an NSE Symbol of LYKALABS and ISIN of INE933A01014. It's Registered office is at 4801/B & 4802/A,G I D C Industrial Estate, Ankleshwar-393002, Gujarat. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are D Kothary & Co, MA Parikh & Co, Mehta Chokshi & Shah

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)